Company Atrion Corporation

Equities

ATRI

US0499041053

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
395 ^USD	-0.99%		-1.82%	+4.28%

Apr. 09	Atrion Corporation Announces Not Stand for Re-Election of Hugh J. Morgan, Jr. as Member of Board	CI
Feb. 29	Atrion Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Number of employees: 712

USD in Million	2022	Weight	2023	Weight	Delta
Fluid Delivery 42.0 %	84	45.8 %	71	42.0 %	-15.39%
Cardiovascular 41.2 %	68	36.9 %	70	41.2 %	+3.13%
Other 11.7 %	26	14.1 %	20	11.7 %	-23.85%
Ophthalmology 5.1 %	6	3.2 %	9	5.1 %	+48.37%

USD in Million	2022	Weight	2023	Weight	Delta
United States 62.8 %	110	59.8 %	106	62.8 %	-3.08%
All Other Regions 22.3 %	43	23.7 %	38	22.3 %	-12.96%
European Union 14.9 %	30	16.5 %	25	14.9 %	-17.04%

Managers	Title	Age	Since
David Battat CEO	Chief Executive Officer	54	04-12-31
Cindy Ferguson DFI	Director of Finance/CFO	49	21-06-13

Members of the board	Title	Age	Since
John Stupp BRD	Director/Board Member	74	84-12-31
Preston Athey BRD	Director/Board Member	74	17-03-12
Emile Battat CHM	Chairman	86	86-12-31
Hugh Morgan BRD	Director/Board Member	95	87-12-31
Ronald Spaulding BRD	Director/Board Member	60	06-01-31
Jeannette Bankes BRD	Director/Board Member	53	23-09-19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,419,954	1,357,597 ( 39.70 %)	1,660,000 ( 48.54 %)	39.70 %

Name	Equities	%	Valuation
Kayne Anderson Rudnick Investment Management LLC 11.07 %	194,854	11.07 %	90 M $
LB Hercules Holdings LLC 10.40 %	183,012	10.40 %	85 M $
Emile Battat 8.559 %	150,616	8.559 %	70 M $
John Stupp 8.003 %	140,833	8.003 %	65 M $
T. Rowe Price Investment Management, Inc. 6.562 %	115,477	6.562 %	54 M $
BlackRock Advisors LLC 6.203 %	109,165	6.203 %	51 M $
David Battat 5.393 %	94,900	5.393 %	44 M $
Vanguard Fiduciary Trust Co. 4.804 %	84,550	4.804 %	39 M $
Dimensional Fund Advisors LP 2.839 %	49,958	2.839 %	23 M $
D. F. Dent & Co., Inc. 2.310 %	40,660	2.310 %	19 M $

Atrion Corp.

1 Allentown Parkway

75002-4211, Allen

http://www.atrioncorp.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ATRION CORPORATION	+4.28%	695M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution